Technical Analysis for TNDM - Tandem Diabetes Care, Inc.
| ADX | Long-Term | Intermediate-Term | Short-Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| See historical TNDM trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 50 DMA | Bearish | 0.00% | |
| MACD Bearish Centerline Cross | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | -2.08% | |
| 50 DMA Support | Bullish | -2.08% | |
| Crossed Above 20 DMA | Bullish | -5.32% | |
| Up 3 Days in a Row | Strength | -5.32% | |
| Up 4 Days in a Row | Strength | -5.32% | |
| Crossed Above 50 DMA | Bullish | -4.35% | |
| Up 3 Days in a Row | Strength | -4.35% | |
| 50 DMA Resistance | Bearish | -0.96% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 07/29/2019
- Sector: Healthcare
- Industry: Medical Devices
Tandem Diabetes Care, Inc., a medical device company, focuses on the design, development, and commercialization of various products for people with insulin-dependent diabetes. The company's products include t:slim Insulin Delivery System that comprises t:slim pump, its disposable cartridge, and an infusion set; and t:connect Diabetes Management Application, a PC and Mac-compatible, cloud-based data management application that provides users, their caregivers, and their healthcare providers a fast, easy, and visual way to display therapy management data from the pump and supported blood glucose meters. It sells its products in the United States. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Insulin Endocrinology Diabetes Care Insulin Delivery Diabetes Management Diabetes Mellitus Type 1 Insulin Dependent Diabetes
Medicine Diabetes Healthcare Providers Endocrine System Diabetes Mellitus Insulin Endocrinology Diabetes Care Insulin Delivery Diabetes Management Diabetes Mellitus Type 1 Insulin Dependent Diabetes
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength | |||
| Summary: | Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies. | ||
See more TNDM news...
Indicators
| Indicator | Value |
|---|---|
| 52 Week High | 74.81 |
| 52 Week Low | 20.08 |
| Average Volume | 1,655,918 |
| 200-Day Moving Average | 50.0415 |
| 50-Day Moving Average | 65.0122 |
| 20-Day Moving Average | 67.592 |
| 10-Day Moving Average | 66.34 |
| Average True Range | 3.3616 |
| ADX | 12.63 |
| +DI | 21.5335 |
| -DI | 31.217 |
| Chandelier Exit (Long, 3 ATRs ) | 61.9452 |
| Chandelier Exit (Short, 3 ATRs ) | 71.7948 |
| Upper Bollinger Band | 72.642 |
| Lower Bollinger Band | 62.542 |
| Percent B (%b) | 0.15 |
| BandWidth | 14.942597 |
| MACD Line | -0.1726 |
| MACD Signal Line | 0.3962 |
| MACD Histogram | -0.5688 |
| Fundamentals | Value |
|---|---|
| Market Cap | 321.71 Million |
| Num Shares | 5.02 Million |
| EPS | -25.15 |
| Price-to-Earnings (P/E) Ratio | -2.55 |
| Price-to-Sales | 0.17 |
| Price-to-Book | 0.00 |
| PEG Ratio | 0.00 |
| Dividend | 0.00 |
| Dividend Yield | 0.00% |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 67.71 | ||||
| Resistance 3 (R3) | 67.96 | 66.98 | 67.10 | ||
| Resistance 2 (R2) | 66.98 | 66.04 | 66.86 | 66.90 | |
| Resistance 1 (R1) | 65.51 | 65.47 | 65.02 | 65.26 | 66.69 |
| Pivot Point | 64.53 | 64.53 | 64.28 | 64.41 | 64.53 |
| Support 1 (S1) | 63.06 | 63.59 | 62.57 | 62.82 | 61.39 |
| Support 2 (S2) | 62.08 | 63.02 | 61.96 | 61.18 | |
| Support 3 (S3) | 60.61 | 62.08 | 60.98 | ||
| Support 4 (S4) | 60.37 |
